Wooram C. Park
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
Dual delivery of immunostimulatory oligonucleotides and doxorubicin by magnetic nanoparticles and metal-organic frameworks for antitumor immunotherapy.
Journal: Acta biomaterialia
Published: March 06, 2026
Biomimetic lipid nanoparticles for macrophage reprogramming in cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 12, 2026
A randomized phase III trial of anthracyclines followed by taxane versus taxane plus carboplatin as (neo)adjuvant therapy in patients with triple-negative breast cancer: KCSG BR 15-1 PEARLY trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 08, 2026
Biomimetic Nanogels Programmed for Irreversible-Electroporation-Primed Tumor Microenvironments to Elicit Durable Antitumor Immunity.
Journal: Biomaterials research
Published: November 15, 2025
Engineering Mesenchymal Stem Cells with Nanomaterials for Tumor Microenvironment Regulation and Precision Therapy.
Journal: Tissue engineering and regenerative medicine
Published: October 27, 2025
Transforming lipid nanoparticles into radio-activatable therapeutics through synergistic ferroptosis for enhanced cancer radiotherapy.
Journal: Biomaterials
Published: October 19, 2025
Photosensitizing Lipid Nanoparticles for Ferroptosis-Enhanced Photodynamic Cancer Therapy via GPX4 Silencing.
Journal: Advanced healthcare materials
Published: August 01, 2025
Synergistic immunotherapeutic effects of irreversible electroporation and CAR-NK cell therapy against hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: May 28, 2025
Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases.
Journal: Advanced healthcare materials
Published: April 25, 2025
Apolipoprotein Fusion Enables Spontaneous Functionalization of mRNA Lipid Nanoparticles with Antibody for Targeted Cancer Therapy.
Journal: ACS nano
Published: February 05, 2025
Corrigendum to "Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer" [Biomed. Pharmacother. 182 (2025) 117795].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 11, 2025
Last Updated: 09/26/2026